Combined intravitreal bevacizumab and triamcinolone acetonide injection for idiopathic neuroretinitis.

Full Abstract

PURPOSE: To present a case with idiopathic neuroretinitis that was treated with combined intravitreal bevacizumab and triamcinolone. DESIGN: Case report. METHODS: Interventional case report. RESULTS: A 31-year-old man presented with a visual acuity of 3/10 and afferent pupillary defect in the right eye. Ophthalmologic examination disclosed papillitis and macular edema. Neurology consultation with cranial computerized tomography scan revealed no abnormality. The patient was injected with bevacizumab and triamcinolone intravitreally. One week later, the vision increased to 10/10, macular edema disappeared. One month later, optic disc edema disappeared. CONCLUSIONS: Intravitreal injection of bevacizumab and triamcinolone effectively treated idiopathic neuroretinitis.

Author information

Author/s: Cakir, Mehmet (M); Cekiç, Osman (O); Bozkurt, Ercüment (E); Pekel, Gökhan (G); Yazici, Ahmet T (AT); Yilmaz, Omer F (OF);

Affiliation: Beyoglu Eye Training and Research Hospital, Istanbul, Turkey. drmcakir(-atsign-)hotmail.com

Journal and publication information

Publication Type: Case Reports; Journal Article

Journal: Ocular immunology and inflammation (Ocul Immunol Inflamm), published in England. (Language: eng)

Reference: -2009 May-Jun; vol 17 (issue 3) : pp 221-3

Dates: Created 2009/07/08; Completed 2009/09/02;

PMID: 19585368, status: MEDLINE (last retrieval date: 9/4/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MESH Headings shown below.

Adult
Angiogenesis Inhibitors - therapeutic use
Antibodies, Monoclonal - therapeutic use
Drug Therapy, Combination
Fluorescein Angiography
Glucocorticoids - therapeutic use
Humans
Injections

Associated Chemicals: Angiogenesis Inhibitors (0) ; Antibodies, Monoclonal (0) ; Glucocorticoids (0) ; Vascular Endothelial Growth Factor A (0) ; bevacizumab (0) ; Triamcinolone Acetonide (76-25-5)

These are the highest related articles currently in the database: